Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks

20 Nov 2023

Abstract excerpt

Background: Polycystic ovary syndrome (PCOS) affects women of reproductive age globally with an incidence rate of 5% - 26%. Growing evidence reports important roles for microRNAs (miRNAs) in the pathophysiology of granulosa cells (GCs) in PCOS. Objectives: The objectives of this study were to identify the top differentially expressed miRNAs (DE-miRNAs) and their corresponding targets in hub gene-miRNA networks,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Ovarian function and disorders
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38444712
DOI: 10.5812/ijpr-139985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA NetworksPMID 38444712Read ↗

The identification of key immune related genes and pathways in polycystic ovary syndrome by bioinformatics analysis of Single-cell RNA sequencing dataSemantic proximity Read ↗

Bioinformatics identification of microRNAs involved in�polycystic ovary syndrome based on microarray dataSemantic proximity Read ↗

Integrative Multi-cohort Transcriptomics and Network Pharmacology Analysis Reveals Key Network Nodes and Potential Drug Clues in PCOS Granulosa CellsSemantic proximity Read ↗

Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic moleculesSemantic proximity Read ↗

Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in ChinaSemantic proximity Read ↗

Identification of Key Pathways and Genes in Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis and Prediction of Small Therapeutic MoleculesSemantic proximity Read ↗

Transcriptome profiling reveals dysregulation of inflammatory and protein synthesis genes in PCOSSemantic proximity Read ↗

Key genes and pathways of ovarian granulosa cells in polycystic ovary syndrome identified by bioinformatics analysisSemantic proximity Read ↗

The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics AnalysisSemantic proximity Read ↗

Explore the potential molecular mechanism of polycystic ovarian syndrome by protein–protein interaction network analysisSemantic proximity Read ↗

Identification of the core ontologies and signature genes of polycystic ovary syndrome (PCOS): A bioinformatics analysisSemantic proximity Read ↗

Bioinformatics Analysis of RNA Sequencing Data Identifies Biomarkers and Treatment Targets in PreeclampsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.